Catalent Experts to Lead Multiple Workshops on Challenging Clinical Supply Topics at Upcoming GCSG Conference

SOMERSET, N.J., April 19, 2018 /PRNewswire-PRWeb/ -- Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that several of its clinical supply experts are to lead four workshops at the upcoming Global Clinical Supplies Group (GCSG) Conference, to be held at the Grand Hyatt Atlanta in Buckhead, Atlanta, Georgia, on April 29 – May 2, 2018.

Advertisement

The four workshops will each be presented multiple times throughout the conference, and will cover a broad range of current topics within the clinical supply industry focusing on:

• Successfully Developing a Global, Decentralized Model in a Demand Led Environment (co-presentation with Novartis)
• Mitigating Importer of Record and Value Added Tax Risk (co-presentation with Alnylam Pharmaceuticals)
• Import/Export Considerations for Temperature Controlled Clinical Supplies (co-presentation with Pelican BioThermal)
• Bridging the Cultural Gap in Japanese Clinical Trials (co-presentation with Astellas Pharma)

"Catalent is proud to support the upcoming GCSG conference and help to advance many of the important topics facing the clinical supply industry," said Bernie Clark, Vice President of Marketing and BU Strategy. "Sharing our knowledge and encouraging innovative approaches and technologies is critical to meeting the demands our customers face in streamlining clinical trials and better serving patients every day."

For more information on these workshops or the GCSG Conference, visit catalent.com/GCSG. To arrange a meeting with attending Catalent executives at the event, contact Richard Kerns at NEPR – richard(at)nepr.eu.

About Catalent Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With over 80 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs approximately 11,000 people, including over 1,400 scientists, at more than 30 facilities across five continents, and in fiscal 2017 generated over $2 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit http://www.catalent.com

More products. Better treatments. Reliably supplied.™

 

SOURCE Catalent, Inc.